Tag Archives: after

Roche pulls Tecentriq breast cancer nod after post-approval trial flop

Just two years ago, Roche’s Tecentriq was heralded as the first PD-1/L1 treatment to win an approval in triple-negative breast cancer. However, the approval was conditional on a postmarketing study on the Tencentriq and Celgene’s Abraxane combo which later failed.  Now Roche is pulling the plug.  The Swiss pharma on Friday announced that it has voluntarily withdrawn its accelerated approval for Tecentriq in… Read More »

Exercise after microblading: All your questions answered

One of the notorious no-nos after microblading is exercising, which many customers noticed has ruined the effect and speeded up colour fading. This leads to more frequent touch-ups and redos, making the whole treatment expensive and rather pointless. Here’s everything you need to know about microblading and working out: why it’s not recommended, how long you… Read More »